Annual Drug Patent Expirations for EDURANT
Edurant is a drug marketed by Janssen Prods and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
Drug patent litigation for EDURANT.
This drug has one hundred and eigthy-six patent family members in forty-two countries.
The generic ingredient in EDURANT is rilpivirine hydrochloride. One supplier is listed for this compound. Additional details are available on the rilpivirine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
